Global Fund, Stop TB Partnership and USAID Announce New Coll

The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) announced today a new collaboration with Danaher Corporation (Danaher), a global science and technology innovator who will provide Cepheid’s Xpert® MTB/RIF Ultra diagnostic test cartridges for tuberculosis (TB) at the price of US$7.97, a 20% reduction from the current price of US$9.98.

Related Keywords

Geneva , Genè , Switzerland , Lucica Ditiu , Peter Sands , Atul Gawande , Global Fund , Cepheid , Administrator For Global Health , Global Fund To Fight , Us Agency For International Development , Danaher Corporation , Tb Partnership , New Collaboration , Reduce Price , Increase Access , International Development , Executive Director , Global Health , Nextgen Market Shaping , Stop Tb Partnership , Usaid , Announce , New , Collaboration , Danaher , Reduce , Price , Increase , Access , Tb , Test ,